For Those Who Are Serious About Increasing Access to MAT for Opioid Use Disorder…

By Jeffrey A. Singer The synthetic opioid methadone, developed in Germany in the 1930s for the treatment of severe pain, has been employed for the Medication Assisted Treatment (MAT) of heroin addiction and opioid use disorder since the 1960s. In the US, methadone clinics are tightly regulated by the Drug Enforcement Administration and the Substance Abuse Read More

Preventing opioid misuse and addiction: New thinking and the latest evidence

Drug policy often comprises efforts to reduce the supply of drugs, to provide health and social services to addicted individuals, and to prevent the development of addiction in the first place. The last of these efforts—prevention—is the subject of this paper. The scientific literature on drug policy offers some insights on the relative effectiveness and Read More

Don’t Skip Opiates for ‘Air Hunger’ From COVID-19 Ventilation

Easing the traumatic “air hunger” created by mechanical ventilation settings for COVID-19 acute respiratory distress syndrome (ARDS) may take more than just sedation or paralytics, one group argued. Lung protective ventilation, with low tidal volumes and permissive hypercapnia, is a recipe for “the most uncomfortable form of dyspnea,” Richard Schwartzstein, MD, of Beth Israel Deaconess Medical Center Read More

Authorities nationwide are reporting an uptick in fatal opioid overdoses during social distancing.

Lynn sat in the parking lot of her opioid treatment clinic in Columbus, Ohio, for hours on a recent Tuesday. Like in other parts of the country, the coronavirus pandemic was leading to longer wait times for medication—in this case, Suboxone. Around her, people idled in their cars or stood in a smoking area until the doctor called Read More